HEADER TRANSLATION 20-OCT-08 2W1O TITLE NMR STRUCTURE OF DIMERIZATION DOMAIN OF HUMAN RIBOSOMAL TITLE 2 PROTEIN P2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 60S ACIDIC RIBOSOMAL PROTEIN P2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 1-69; COMPND 5 SYNONYM: RENAL CARCINOMA ANTIGEN NY-REN-44, HUMAN RIBOSOME COMPND 6 PROTEIN P2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET3D KEYWDS RIBOSOMAL PROTEIN, RIBONUCLEOPROTEIN, RIBOSOME, KEYWDS 2 TRANSLATION, DIMERIZATION, PHOSPHOPROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR K.M.LEE,D.S.CHAN,K.H.SZE,G.ZHU,P.C.SHAW,K.B.WONG REVDAT 3 08-SEP-10 2W1O 1 JRNL DBREF SEQADV REVDAT 2 28-APR-10 2W1O 1 AUTHOR JRNL REMARK REVDAT 1 17-NOV-09 2W1O 0 JRNL AUTH K.M.LEE,C.W.YU,D.S.CHAN,T.Y.CHIU,G.ZHU,K.H.SZE, JRNL AUTH 2 P.C.SHAW,K.B.WONG JRNL TITL SOLUTION STRUCTURE OF THE DIMERIZATION DOMAIN OF JRNL TITL 2 RIBOSOMAL PROTEIN P2 PROVIDES INSIGHTS FOR THE JRNL TITL 3 STRUCTURAL ORGANIZATION OF EUKARYOTIC STALK. JRNL REF NUCLEIC ACIDS RES. V. 38 5206 2010 JRNL REFN ISSN 0305-1048 JRNL PMID 20385603 JRNL DOI 10.1093/NAR/GKQ231 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE REMARK 3 -KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ REMARK 3 RICE,SIMONSON,WARREN REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1010 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2W1O COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-NOV-08. REMARK 100 THE PDBE ID CODE IS EBI-37827. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : 200MM SODIUM SULFATE REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 90% WATER / 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; COSY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ REMARK 210 SPECTROMETER MODEL : UNITYINOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRVIEW REMARK 210 METHOD USED : ARIA REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 7 REMARK 210 REMARK 210 REMARK: NONE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HA ARG A 2 HD11 LEU B 12 1.57 REMARK 500 HD11 LEU A 12 HA ARG B 2 1.57 REMARK 500 HD22 LEU A 46 HB VAL A 54 1.56 REMARK 500 HB ILE A 51 HB2 ALA B 63 1.52 REMARK 500 HB3 ALA A 63 HB ILE B 51 1.52 REMARK 500 HD22 LEU B 46 HB VAL B 54 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 49 -164.79 -113.75 REMARK 500 1 ILE A 59 -65.60 -103.39 REMARK 500 1 ALA A 63 -79.09 -64.96 REMARK 500 1 PRO A 66 88.17 -60.19 REMARK 500 1 LYS B 49 -165.06 -114.10 REMARK 500 1 ILE B 59 -65.55 -103.17 REMARK 500 1 ALA B 63 -78.99 -64.86 REMARK 500 1 PRO B 66 89.20 -60.35 REMARK 500 2 ARG A 2 -55.87 175.36 REMARK 500 2 LYS A 49 -97.85 -117.06 REMARK 500 2 PRO A 66 93.64 -61.01 REMARK 500 2 ARG B 2 -55.44 175.70 REMARK 500 2 LYS B 49 -97.96 -117.40 REMARK 500 2 PRO B 66 93.67 -60.97 REMARK 500 3 ARG A 2 -56.54 -179.44 REMARK 500 3 SER A 17 78.21 -113.89 REMARK 500 3 LYS A 61 47.51 -89.05 REMARK 500 3 ALA A 63 -118.54 -86.80 REMARK 500 3 SER A 64 49.55 -83.63 REMARK 500 3 ARG B 2 -56.88 -179.87 REMARK 500 3 SER B 17 78.06 -113.99 REMARK 500 3 LYS B 61 47.71 -89.19 REMARK 500 3 ALA B 63 -118.61 -86.58 REMARK 500 4 LYS A 49 -156.21 -103.42 REMARK 500 4 LYS A 61 27.57 -146.59 REMARK 500 4 ALA A 63 -75.91 -60.59 REMARK 500 4 PRO A 66 66.61 -67.10 REMARK 500 4 LYS B 49 -156.12 -103.46 REMARK 500 4 LYS B 61 27.69 -146.51 REMARK 500 4 ALA B 63 -76.11 -60.84 REMARK 500 4 PRO B 66 66.72 -67.03 REMARK 500 5 SER A 17 78.52 -112.39 REMARK 500 5 LYS A 49 -156.19 -116.60 REMARK 500 5 LYS A 61 53.98 -101.35 REMARK 500 5 LEU A 62 -151.46 -137.15 REMARK 500 5 SER A 64 -175.54 68.82 REMARK 500 5 SER B 17 78.57 -112.67 REMARK 500 5 LYS B 49 -155.89 -115.67 REMARK 500 5 LYS B 61 53.53 -101.98 REMARK 500 5 LEU B 62 -151.48 -136.86 REMARK 500 5 SER B 64 -175.17 68.85 REMARK 500 6 ARG A 2 -59.85 -158.75 REMARK 500 6 LYS A 49 -151.48 -103.47 REMARK 500 6 SER A 64 178.97 53.97 REMARK 500 6 PRO A 66 84.15 -50.21 REMARK 500 6 ARG B 2 -59.72 -159.06 REMARK 500 6 LYS B 49 -151.49 -103.67 REMARK 500 6 SER B 64 179.18 54.09 REMARK 500 6 PRO B 66 84.26 -50.46 REMARK 500 7 ARG A 2 -58.54 -141.97 REMARK 500 REMARK 500 THIS ENTRY HAS 83 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1S4J RELATED DB: PDB REMARK 900 NMR STRUCTURE OF CROSS-REACTIVE PEPTIDES REMARK 900 FROM HOMO SAPIENS REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SUBMITTED SEQUENCE CONTAINS THE N-TERMINAL DIMERIZATION REMARK 999 DOMAIN (RESIDUE 1-69) OF HUMAN P2, AND AN EXTRA N-TERMINAL REMARK 999 ALA RESIDUE AS A CLONING ARTEFACT. DBREF 2W1O A 1 69 UNP P05387 RLA2_HUMAN 1 69 DBREF 2W1O B 1 69 UNP P05387 RLA2_HUMAN 1 69 SEQADV 2W1O ALA A -1 UNP P05387 EXPRESSION TAG SEQADV 2W1O ALA B -1 UNP P05387 EXPRESSION TAG SEQRES 1 A 70 ALA MET ARG TYR VAL ALA SER TYR LEU LEU ALA ALA LEU SEQRES 2 A 70 GLY GLY ASN SER SER PRO SER ALA LYS ASP ILE LYS LYS SEQRES 3 A 70 ILE LEU ASP SER VAL GLY ILE GLU ALA ASP ASP ASP ARG SEQRES 4 A 70 LEU ASN LYS VAL ILE SER GLU LEU ASN GLY LYS ASN ILE SEQRES 5 A 70 GLU ASP VAL ILE ALA GLN GLY ILE GLY LYS LEU ALA SER SEQRES 6 A 70 VAL PRO ALA GLY GLY SEQRES 1 B 70 ALA MET ARG TYR VAL ALA SER TYR LEU LEU ALA ALA LEU SEQRES 2 B 70 GLY GLY ASN SER SER PRO SER ALA LYS ASP ILE LYS LYS SEQRES 3 B 70 ILE LEU ASP SER VAL GLY ILE GLU ALA ASP ASP ASP ARG SEQRES 4 B 70 LEU ASN LYS VAL ILE SER GLU LEU ASN GLY LYS ASN ILE SEQRES 5 B 70 GLU ASP VAL ILE ALA GLN GLY ILE GLY LYS LEU ALA SER SEQRES 6 B 70 VAL PRO ALA GLY GLY HELIX 1 1 MET A 1 GLY A 13 1 13 HELIX 2 2 SER A 19 GLY A 31 1 13 HELIX 3 3 ASP A 36 LYS A 49 1 14 HELIX 4 4 ASN A 50 ILE A 59 1 10 HELIX 5 5 GLY A 60 ALA A 63 5 4 HELIX 6 6 MET B 1 GLY B 13 1 13 HELIX 7 7 SER B 19 GLY B 31 1 13 HELIX 8 8 ASP B 36 LYS B 49 1 14 HELIX 9 9 ASN B 50 ILE B 59 1 10 HELIX 10 10 GLY B 60 ALA B 63 5 4 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1